Macular Edema – Pipeline Review, H1 2012 (Related Reports)

Macular Edema – Pipeline Review, H1 2012


March 19, 2012
65 Pages - SKU: GMD3811075
License type:
Online Download      US $500.00
Global Site License      US $1,500.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018
4/14/2014 | published by: MarketsandMarkets
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018 The global cell analysis market  |  read more...
$4,650.00
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
4/14/2014 | published by: GBI Research
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma  |  read more...
$3,500.00
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
4/14/2014 | published by: GBI Research
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth Summary The leading business intelligence provider GBI Research has released its latest research report,  |  read more...
$3,500.00
Conference Documentation: Asthma & COPD
4/2/2014 | published by: SMI Publishing, Ltd
Conference Documentation: Asthma & COPD SMi proudly present their 10th annual Asthma and COPD conference taking place in Central London on Wednesday 2nd and Thursday 3rd April, 2014.  This year’s event will focus  |  read more...
$788.78
PharmaPoint: Migraine - Current and Future Players
3/31/2014 | published by: GlobalData
PharmaPoint: Migraine - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Migraine - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in  |  read more...
$2,995.00
OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018
3/12/2014 | published by: GlobalData
OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018 Summary Autism Spectrum Disorders (ASD) is a chronically underserved market currently dominated by the two approved drugs, both of which are antipsychotics. There is off-label use  |  read more...
$5,995.00
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014
3/12/2014 | published by: GlobalData
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 provides data on the Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This  |  read more...
$2,500.00
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability
3/14/2014 | published by: GBI Research
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability Summary GBI Research, the leading business intelligence provider, has released its latest research, Epilepsy Therapeutics  |  read more...
$3,500.00
Mass Spectrometry Market - by Technology (Tandem LC - MS/ Quadrupole/ ICP - MS/ Gas Chromatography - MS/ TOF - MS/ MALDI -TOF/ Fourier Transform - MS) & by Application (Pharmaceutical/ Biotechnology/ Environment/ Food & Beverages) - Global Trends & Foreca
3/14/2014 | published by: MarketsandMarkets
Mass Spectrometry Market - by Technology (Tandem LC - MS/ Quadrupole/ ICP - MS/ Gas Chromatography - MS/ TOF - MS/ MALDI -TOF/ Fourier Transform - MS) & by Application (Pharmaceutical/ Biotechnology/ Environment/ Food &  |  read more...
$4,650.00